Jay Traverse, MD
Enriched profileSenior Consulting Cardiologist; Director of Research, Minneapolis Heart Institute Foundation · Minneapolis Heart Institute at Abbott Northwestern Hospital
Jay Traverse is Senior Consulting Cardiologist; Director of Research, Minneapolis Heart Institute Foundation at Minneapolis Heart Institute at Abbott Northwestern Hospital. OpenAlex indexes 266 publications with 12,362 citations (h-index 51); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Jay Traverse, MD, is Senior Consulting Cardiologist at Minneapolis Heart Institute at Abbott Northwestern Hospital. The public record shows 266 publications with 12,362 citations (h-index 51), centered on Mesenchymal stem cell research, Cardiac Imaging and Diagnostics, Tissue Engineering and Regenerative Medicine. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 15 companies, 2 NIH-funded awards (1994–2014).
- Most recent indexed publication: 2026 · Circulation. Cardiovascular interventions
- Top research focus: Mesenchymal stem cell research
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 119.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- SuperSaturated Oxygen Comprehensive Observational Registry
Sponsor: TherOx
- Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Sponsor: Minneapolis Heart Institute Foundation
- Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Sponsor: Shockwave Medical, Inc.
Industry payments
Updated 15 Oct 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202517 payments$20,300openpaymentsdata.cms.gov ↗
- Bard Peripheral Vascular, Inc.Program year20253 payments$10,494openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year202511 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
90.1%Beta blocker22.5%Metoprolol Succinate39%Carvedilol31%Metoprolol Tartrate21%Atenolol10%Part D<11 patientsStatin21.1%Atorvastatin Calcium54%Rosuvastatin Calcium39%Pravastatin Sodium7%Part D<11 patients+ 11 more classes in this area
Blood & clotting
8.8%Factor Xa inhibitor4.8%Eliquis100%Part D≥18 patientsP2Y12 inhibitor4%Clopidogrel100%Part D≥18 patientsMusculoskeletal
1.1%Xanthine oxidase inhibitor1.1%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 15 Oct 2026
2 NIH research awards on record, funded 1994–2014 per NIH RePORTER. The latest:
- Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI
University of Minnesota
FY2014$206,341R01HL103927 - Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI
University of Minnesota
FY2013$541,765R01HL103927 - Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI
University of Minnesota
FY2012$567,987R01HL103927
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Association Between Artificial Intelligence-Detected Features on the ECG and Presence of Microvascular Obstruction.
Circulation. Cardiovascular interventions
Article2026 - Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD.
Journal of the American Society of Nephrology
Article2025 - Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial.
Circulation. Cardiovascular interventions
Clinical Trial2025 - Causes of long-term mortality in patients with ST-segment elevation myocardial infarction is dictated by the presence of microvascular obstruction.
European heart journal open
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jay-traverse-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
mplsheart.org/jay-h-traverse-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mplsheart.org ↗ - LinkedIn
it.linkedin.com/in/jay-traverse-36a16158
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →it.linkedin.com ↗ - ResearchGate
researchgate.net/profile/Jay-Traverse-2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Cardiology & Interventional Cardiology Fellowship
University of Minnesota Medical School, Cardiovascular Division
1996verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
Editorial & leadership roles
journal and society appointmentsSecondary affiliations
appointments beyond the home institution- Associate Professor of Medicine
Department of Cardiology, University of Minnesota Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mplsheart.org ↗
Media & interviews
press, podcasts and appearances- Guest
Minneapolis Heart Institute Foundation Cardiology Grand Rounds Podcast, reviewed LateTIME, SCIPIO, and CADUCEUS stem-cell trial results with Dr. Timothy Henry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mplsheart.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)